Antagonist

Results: 956



#Item
91ModuleLabelling PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON

ModuleLabelling PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON

Add to Reading List

Source URL: mri.medagencies.org

Language: English - Date: 2014-11-21 04:31:32
92HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EDARBYCLOR safely and effectively. See full prescribing information for EDARBYCLOR. EDARBYCLOR (azilsartan medoxomil

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EDARBYCLOR safely and effectively. See full prescribing information for EDARBYCLOR. EDARBYCLOR (azilsartan medoxomil

Add to Reading List

Source URL: arborpatientdirect.com

Language: English - Date: 2015-04-01 09:52:54
93ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1  1.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1.

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2015-01-22 11:10:22
9426 March 2015 EMA/CHMPCommittee for Medicinal Products for Human Use (CHMP) Summary of opinion 1 (initial authorisation)

26 March 2015 EMA/CHMPCommittee for Medicinal Products for Human Use (CHMP) Summary of opinion 1 (initial authorisation)

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2015-03-27 08:09:02
95SUMMARY OF PRODUCT CHARACTERISTICS  1. NAME OF THE MEDICINAL PRODUCT

SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT

Add to Reading List

Source URL: mri.medagencies.org

Language: English - Date: 2015-05-08 19:03:48
9613 MAYThe Crafoord Prize Lectures 2009 held by the Crafoord Prize Laureates in polyarthritis 2009 on 13 May in Fernströmsalen BMC, Lund University, Sweden

13 MAYThe Crafoord Prize Lectures 2009 held by the Crafoord Prize Laureates in polyarthritis 2009 on 13 May in Fernströmsalen BMC, Lund University, Sweden

Add to Reading List

Source URL: www.crafoordprize.se

Language: English - Date: 2013-10-14 18:19:58
97A Single Subcutaneous Dose of 2 mg/kg or 4 mg/kg of RG-101, a GalNAc-Conjugated Oligonucleotide with Antagonist Activity against miR-122, Results in Significant Viral Load Reductions in Chronic Hepatitis C  Patients

A Single Subcutaneous Dose of 2 mg/kg or 4 mg/kg of RG-101, a GalNAc-Conjugated Oligonucleotide with Antagonist Activity against miR-122, Results in Significant Viral Load Reductions in Chronic Hepatitis C Patients

Add to Reading List

Source URL: files.shareholder.com

Language: English
98Molecular Pain  BioMed Central Open Access

Molecular Pain BioMed Central Open Access

Add to Reading List

Source URL: www.molecularpain.com

Language: English
99SYMPOSIUM REPORT SUPPLEMENT  Pharmacology of Antihistamines Diana S. Church, MD, and Martin K. Church, PhD, DSc  Abstract: This article reviews the molecular biology of the interaction of histamine with its H1-receptor a

SYMPOSIUM REPORT SUPPLEMENT Pharmacology of Antihistamines Diana S. Church, MD, and Martin K. Church, PhD, DSc Abstract: This article reviews the molecular biology of the interaction of histamine with its H1-receptor a

Add to Reading List

Source URL: www.waojournal.org

Language: English
100Kwartaalbericht 4e kwartaalNovember 2005  Contents

Kwartaalbericht 4e kwartaalNovember 2005 Contents

Add to Reading List

Source URL: www.lareb.nl

Language: English